Specialties
Funded grants
Revised 10/18/2012
| Principal Investigator | Source | Title | Total Award |
| Leonard Abbeduto, Ph.D. | National Fragile X Foundation | Parent Mediated Language Intervention for Young Children with Fragile X Syndrome: A Pilot Efficacy Study | $50,868 |
| National Institutes of Health | Interdisciplinary Training Conference in Developmental Disabilities | $60,000 | |
| National Institutes of Health | Language Development in Fragile X Syndrome | $2,644,596 | |
| University of Alabama and National Institutes of Health |
Cognitive Predictors of Language Impairment in Down Syndrome | $151,590 | |
| National Institutes of Health | Social-Affective Bases of Word Learning in Fragile X Syndrome and Autism | $703,969 | |
| David Amaral, Ph.D. | Allen Institute for Brain Science and National Institutes of Health |
Creating a Developmental Gene Expression Atlas for Rhesus Macaque Brain | $508,775 |
| National Institute of Neurological Disorders and Stroke | Functional Organization of the Hippocampal Formation | $2,653,071 | |
| National Institutes of Health | Neurobiology of Social Behavior | $3,710,304 | |
| National Institutes of Health | A Novel, Transient Inactivation Technique for Studying the Primate Social Brain | $422,453 | |
| UC San Diego and National Institutes of Health |
Creating a Pediatric Imaging Genomics Data Resource | $435,820 | |
| SynapDx | Research Agreement with SynapDx | $14,546 | |
| Melissa Bauman, Ph.D. | National Institutes of Health | Efficacy of a Novel Neuroprotective Compound in Nonhuman Primates | $437,266 |
| Eliza Bliss-Moreau, Ph.D. | National Institutes of Health Fellowship | The Anterior Cingulate Cortex's Role in Normal Social Behavior | $156,430 |
| Cameron Carter, M.D. | National Institutes of Health | Interdisciplinary Training Program in Neurotherapeutics | $930,942 |
| Jacqueline Crawley, Ph.D. | Stanford University and Simons Foundation |
16p11.2 Deletion Mice: Autism-Relevant Phenotypes and Treatment Discovery | $600,000 |
| University of Medicine and Dentistry, New Jersey | En2 Regulates Forebrain Monoamines and Behavior | $91,555 | |
| Simons Foundation | Standarized Behavioral and EEG Phenotyping of Mouse Models of Autism | $408,766 | |
| NeuroTherapeutics Pharma, Inc. | Pilot Study to Test the Effects of an NTP Compound in a Mouse Model of Autism | $76,955 | |
| UC San Francisco | Gene Discovery and Neurodevelopment Analysis in a Mouse Model of Autism | $121,426 | |
| National Institutes of Health | Novel Anticonvulsant Neuroprotective Therapies for TETS and OP Intoxication | $98,908 | |
| Catherine Fassbender, Ph.D. | National Institutes of Health | Identifying Cognitive and Neural Risk Factors for Substance Dependence in ADHD | $230,688 |
| Irwin Feinberg, M.D. | National Institutes of Health | Longitudinal Measurements of Sleep EEG in Adolescents | $2,206,983 |
| National Institutes of Health | Longitudinal Measurements of Sleep EEG in Adolescence | $186,295 | |
| David Hessl, Ph.D. | National Institutes of Health | Limbic System Function in Carriers of the Fragile X Premutation | $1,558,710 |
| National Institutes of Health | Limbic System Function in Carriers of the Fragile X Premutation Competitive Revision | $775,470 | |
| National Fragile X Foundation | Extending Autism Behavioral Intervention to Young Children with Fragile X Syndrome | $50,000 | |
| W. Ladson Hinton, M.D. | Harry and Jeanette Weinberg Foundation, Inc. | Sacramento Asian Pacific Islander Dementia Care Network | $51,600 |
| University of Washington | National Alzheimer's Coordinating Center | $51,594 | |
| National Institutes of Health | Reducing Disparities in Depression Care for Ethnically Diverse Older Men | $1,751,535 | |
| National Institutes of Health | Center to Advance Cognitive Health and Healthcare in Older Latinos | $2,508,048 | |
| Robert Horst, M.D. | Klingenstein Foundation | Fellowship Program in Child and Adolescent Psychiatry at UC Davis | $12,000 |
| Ryan Johnson, Ph.D. | National Institutes of Health | Amygdala Connectivity in Autism Spectrum Disorder | $102,514 |
| Michael Minzenberg, M.D. | Doris Duke Foundation | Neuroimaging of Locus Coeruleus Modulation for Cognitive Disability of Schizophrenia | $405,000 |
| The Dana Foundation | Locus Coeruleus Neuroimaging of Antipsychotic/Modafinil Interactions on Cognition in Schizophrenia | $200,000 T | |
| Tara Niendam, Ph.D. | National Institutes of Health | Cognitive Neuroscience of the Psychosis Prodrome | $792,930 |
| Sally Ozonoff, Ph.D. | National Institutes of Health | Infants at Risk of Autism: A Longitudinal Study | $2,968,419 |
| University of Alberta and Simons Foundation |
Genomic Influences on Development and Outcomes in Infants at Risk of ASD | $464,488 | |
| University of Alberta and Autism Speaks |
Genomic Influences on Developmental Course and Outcomes in Infants at Risk of ASD: A BSRC Study | $26,462 | |
| Sally Rogers, Ph.D. | Autism Speaks | Meta-Analystic Project for the Autism Speaks Toddler Treatment Network | $19,140 |
| National Institutes of Health | A Multi-Site Randomized Study of Intensive Treatment for Toddlers with Autism | $15,313,404 | |
| National Institutes of Health | Interdisciplinary Training for Autism Researchers | $1,684,766 | |
| Department of Education and University of North Carolina |
The Professional Development Center: Children Autism Spectrum Disorders (PDA) | $1,307,029 | |
| Autism Speaks | Strenghening the Effects of Parent-Implemented Early Intervention to Improve Symptoms of ASD | $765,937 | |
| University of North Carolina and Institute of Education Sciences |
Center on Secondary Education for Students with Autism Spectrum Disorders (CSESA) | $2,126,220 | |
| Ruth Salo, Ph.D. | National Institutes of Health | Neural and Cognitive Correlative of Methamphetamine Use in Schizophrenia | $1,305,208 |
| Cynthia Schumann, Ph.D. | National Institutes of Health | Typical and Pathological Cellular Development of the Human Amygdala | $1,923,750 |
| Julie Schweitzer, Ph.D. | Otsuka Pharmaceutical Group and Covance |
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed Dose Once-weekly Oral Aripiprazole in Children and Adolescents with Tourette's Disorder | $90,333 |
| Otsuka Pharmaceutical Group and Covance |
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents with Tourette's Disorder | $104,233 | |
| National Institutes of Health | Developmental Changes in Neural Processes Underlying Impulsivity and ADHD | $2,979,419 | |
| Amy Schwichtenberg, Ph.D. | National Institutes of Health | Self-Regulation and Sleep in Children at Risk for Autism Spectrum Disorders | $180,000 |
| Andreea Seritan, M.D. | Substance Abuse and Mental Health Services Administration | Healthy Climate, Happy Students | $306,000 |
| Tony Simon, Ph.D. | Dempster Family Foundation | Chromosome 22q11.2 Deletion Syndrome Healthy Minds Clinic | $20,111 |
| National Institutes of Health | Fragile X Spectrum as a Model to Explore Neurogenetic Mechanism of Cognitive Dysfunction | $2, 093,514 | |
| National Institutes of Health | Visuospatial Cognitive Deficit in Del22q11.3 Syndrome | $3,348,283 | |
| National Institutes of Health | Visuospatial Cognitive Deficit in Del22q11.2 Syndrome | $56,790 | |
| Christine Wu Nordahl, Ph.D. | National Institutes of Health | Analyses of Brain Structure and Connectivity in Young Children with Autism | $730,462 |
| Guohua Xia, M.D. | Brainsway | A Prospective Multicenter Double-blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD) | $190,373 |
| Glen Xiong, M.D. | Brain and Behavior Research Foundation (NARSAD) | The Development of an Automated System for the Classification of fMRI Activation Patterns as a Diagnosis | $60,000 |
| Peter Yellowlees, M.D. | Defense Advanced Research Projects Agency (Comprehensive Interior Reconnaissance) | Detection and Computational Analysis of Psychological Signals | $400,646 |
| Jong Yoon, M.D. | National Institutes of Health | fMRI Investigation of Maintenance in Schizophrenia | $838,315 |
| National Institutes of Health | GABA Deficit Hypothesis of Impaired Visual Inhibition in Schizophrenia | $421,604 | |
| Brain and Behavior Research Foundation (NARSAD) | The Development of a Brain Activity Based Classification System to Identify Neurophysiologically Similar Sub-Groups Within the Schizophrenia Syndrome | $60,000 | |
| Gregory Young, Ph.D. | Autism Speaks | A Centralized Standard Database for the Baby Siblings Research Consortium | $125,581 |
| National Institutes of Health | Neurocognitive Markers of Response to Treatment in Autism | $152, 924 |
